Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01108458
Brief Title: A Phase 2 Study of Pertuzumab and Erlotinib for Refractory Pancreatic Adenocarcinoma

First Submitted : April 20, 2010
First Submitted that Met QC Criteria : April 21, 2010
First Posted : April 22, 2010 (Estimate)

Results First Submitted : January 12, 2017
Results First Submitted that Met QC Criteria : January 12, 2017
Results First Posted : March 3, 2017

Last Update Submitted that Met QC Criteria : January 12, 2017
Last Update Posted : March 3, 2017